Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome
Clinical Autonomic Research · 2023
DOI: 10.1007/s10286-023-00922-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Autonomic Research, 2023. Verfasst von Paul-Adrian Călburean und 19 weiteren Autor:innen. Beteiligte Einrichtung: Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brus…. Hauptthemen laut MEDLINE: Ajmaline, Brugada Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Drug-induced type I Brugada syndrome (BrS) is associated with a ventricular arrhythmia (VA) rate of 1 case per 100 person-years. This study aims to evaluate changes in electrocardiographic (ECG) parameters such as microvolt T wave alternans (mTWA) and heart rate variability (HRV) at baseline and during ajmaline testing for BrS diagnosis. METHODS: Consecutive patients diagnosed with BrS during ajmaline testing with 5-year follow-up were included in this study. For comparison, a negative ajmaline control group and an isoproterenol control group were also included. ECG recordings during ajmaline or isoproterenol test were divided in two timeframes from which ECG parameters were calculated: a 5-min baseline timeframe and a 5-min drug timeframe. RESULTS: A total of 308 patients with BrS were included, 22 (0.7%) of which suffered VAs during follow-up. One hundred patients were included in both isoproterenol and negative ajmaline control groups. At baseline, there was no difference in ECG parameters between control groups and patients with BrS, nor between BrS with and without VAs. During ajmaline testing, BrS with VAs presented longer QRS duration [159 ± 34 ms versus 138 (122-155) ms, p = 0.006], higher maximum mTWA [33.8 (14.0-114) µV versus 8.00 (3.67-28.2) µV, p = 0.001], and lower power in low frequency band [25.6 (5.8-53.8) ms2 versus 129.5 (52.7-286) ms2, p < 0.0001] when compared to BrS without VAs. CONCLUSIONS: Ajmaline induced important HRV changes similar to those observed during isoproterenol. Increased mTWA was observed only in patients with BrS. BrS with VAs during follow-up presented worse changes during ajmaline test, including lower LF power and higher maximum mTWA which were independent predictors of events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Laarbeeklaan 101, 1090,…
- George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Targu Mures, Romania.
- Genetics Department, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.
- Cardiac Surgery Department, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
ORCID-Profile: Carlo de Asmundis
Zitieren
APA
Călburean, P. A., Pannone, L., Sorgente, A., Gauthey, A., Monaco, C., Strazdas, A., Almorad, A., Bisignani, A., Bala, G., Ramak, R., Overeinder, I., Ströker, E., Pappaert, G., Van Dooren, S., de Ravel, T., La Meir, M., Brugada, P., Sieira, J., Chierchia, G. B., & de Asmundis, C. (2023). Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome. Clinical Autonomic Research. https://doi.org/10.1007/s10286-023-00922-4
Vancouver
Călburean PA, Pannone L, Sorgente A, Gauthey A, Monaco C, Strazdas A, et al. Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome. Clinical Autonomic Research. 2023. doi:10.1007/s10286-023-00922-4
BibTeX
@article{Clburean2023,
author = {Călburean, Paul-Adrian and Pannone, Luigi and Sorgente, Antonio and Gauthey, Anaïs and Monaco, Cinzia and Strazdas, Antanas and Almorad, Alexandre and Bisignani, Antonio and Bala, Gezim and Ramak, Robbert and Overeinder, Ingrid and Ströker, Erwin and Pappaert, Gudrun and Van Dooren, Sonia and de Ravel, Thomy and La Meir, Mark and Brugada, Pedro and Sieira, Juan and Chierchia, Gian-Battista and de Asmundis, Carlo},
title = {Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome},
journal = {Clinical Autonomic Research},
year = {2023},
doi = {10.1007/s10286-023-00922-4}
}
EUVIMED